SUBSCRIPTION AGREEMENT dated as of October 5, 2017 by and between Kleo Pharmaceuticals, Inc. and Biohaven Pharmaceutical Holding Company Ltd. Common Stock US$0.0001 par valueSubscription Agreement • October 12th, 2017 • Biohaven Pharmaceutical Holding Co Ltd. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 12th, 2017 Company Industry JurisdictionTHIS SUBSCRIPTION AGREEMENT, dated as of October 5, 2017 (this “Agreement”), is between Kleo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Biohaven Pharmaceutical Holding Company Ltd., a company formed under the laws of the Territory of the British Virgin Islands (the “Investor”).